Mitsui's Restructured Investment in Chi-Med Worth $84 Million
July 27, 2015 at 06:22 AM EDT
Hutchison Chi-Med and Mitsui have revised Mitsui's investment in Chi-Med by exchanging Mitsui's 12.2% interest in Hutchison MediPharma, the drug development arm of Chi-Med, for a 5.7% interest in the Chi-Med parent company. The 5.7% stake is worth $84 million. Chi-Med owns a TCM company and a consumer health company in addition to its drug development operation. In 2010, Mitsui paid $12.5 million for a 12.2% interest in Chi-Med's drug development arm. More details.... Stock Symbol: (AIM: HCM) Share this with colleagues: // //